Table 2 The clinical and pathological characteristics of 178 patients with and without lymphatic metastasis
| Â | Unmetastatic | Metastatic | P value |
|---|---|---|---|
No | 93 | 85 | – |
Age (years) | 59.35 ± 10.21 | 60.20 ± 11.57 | 0.605 |
BMI (kg/m2) | 23.99 ± 3.24 | 23.05 ± 3.66 | 0.071 |
Sex | |||
 Males | 69 (74.19%) | 58 (68.24%) | 0.380 |
 Females | 24 (25.81%) | 27 (31.76%) | |
Tumor location | |||
 Fundus | 14 (15.05%) | 11 (12.94%) | 0.853 |
 Body | 28 (30.11%) | 24 (28.24%) | |
 Antrum | 51 (54.84%) | 50 (58.82%) | |
Differentiation | |||
 Well and Moderate | 37 (39.78%) | 18 (21.18%) | 0.007** |
 Poor | 56 (60.22%) | 67 (78.82%) | |
Lauren type | |||
 Intestinal-type | 38 (41.30%) | 29 (34.12%) | 0.466 |
 Diffuse | 28 (30.43%) | 33 (38.82%) | |
 Mixed-type | 26 (28.26%) | 23 (27.06%) | |
T stage | |||
 1 | 63 (67.74%) | 12 (14.12%) | < 0.001*** |
 2 | 15 (16.13%) | 16 (18.82%) | |
 3 | 10 (10.75%) | 26 (30.59%) | |
 4 | 5 (5.38%) | 31 (36.47%) | |
N stage | |||
 0 | 93 (100.00%) | 0 (0.00%) | < 0.001*** |
 1 | 0 (0.00%) | 25(29.41%) | |
 2 | 0 (0.00%) | 23(27.06%) | |
 3 | 0 (0.00%) | 37(43.53%) | |
M stage | |||
 0 | 93 (100.00%) | 84 (98.82%) | 0.294 |
 1 | 0 (0.00%) | 1 (1.18%) | |
TNM stage | |||
 I | 78 (83.87%) | 6 (7.06%) | < 0.001*** |
 II | 14 (15.05%) | 27 (31.76%) | |
 III | 1 (1.08%) | 51 (60.00%) | |
 IV | 0 (0.00%) | 1 (1.18%) | |
Adjuvant chemotherapy | |||
 Yes | 26 (30.58%) | 63 (74.12%) | < 0.001*** |
 No | 67 (78.82%) | 22 (25.88%) | |